Industry NewsWashington University Researchers Show Biovica's DiviTum Can Evaluate Ibrance Efficacy After Just Two Weeks Biovica's
Product NewsStudy Results Support Use of DiviTum TK1 Biomarker Assay for Evaluation of Pancreatic Cancer
Product NewsNew Swedish Study at SABCS Shows DiviTum Blood Test Reduces Waiting Times for Evaluating Breast Cancer Treatment
